<qa>  What is BMS-224818?A STUDY OF BMS-224818 BELATACEPT IN PATIENTS WHO HAVE UNDERGONE A KIDNEY TRANSPLANT AND ARE CURRENTLY ON STABLE CYCLOSPORINE OR TACROLIMUS REGIMEN WITH OR WITHOUT CORTICOSTEROIDS: 